Singapore markets close in 1 hour 20 minutes

Puma Biotechnology, Inc. (PBYI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.7500+0.1300 (+2.81%)
At close: 04:00PM EDT
4.7100 -0.04 (-0.84%)
After hours: 05:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
226,628
235,637
228,031
253,155
225,110
Cost of revenue
60,192
62,682
55,093
63,701
39,374
Gross profit
166,436
172,955
172,938
189,454
185,736
Operating expenses
Research development
51,263
50,382
52,240
71,870
97,650
Selling general and administrative
87,581
88,427
89,978
116,294
118,488
Total operating expenses
139,835
139,690
142,218
188,164
216,138
Operating income or loss
26,601
33,265
30,720
1,290
-30,402
Interest expense
13,377
13,330
11,592
12,807
14,046
Total other income/expenses net
267
134
-19,484
-17,445
-15,829
Income before tax
16,531
22,674
457
-28,802
-59,788
Income tax expense
1,156
1,083
455
324
207
Income from continuing operations
15,375
21,591
2
-29,126
-59,995
Net income
15,375
21,591
2
-29,126
-59,995
Net income available to common shareholders
15,375
21,591
2
-29,126
-59,995
Basic EPS
0.07
0.46
0.00
-0.72
-1.52
Diluted EPS
0.07
0.45
0.00
-0.72
-1.52
Basic average shares
46,690
47,134
44,675
40,639
39,576
Diluted average shares
47,129
47,551
44,930
40,639
39,576